5 min listen
A tumultuous week for biotechs
FromFT News in Focus
ratings:
Length:
6 minutes
Released:
Sep 23, 2015
Format:
Podcast episode
Description
Hillary Clinton, the Democratic front runner in the race for the White House, pledged this week to crack down on the growing cost of prescription drugs and out of pocket medical expenses in the United States after Turing Pharmaceuticals announced that it was hiking the price of the drug Daraprim from $13.50 to $750 a pill. Aimee Keane asks David Crow about the sharp falls in biotech stocks that followed and whether plans such as Mrs Clinton's will end price-gouging.
Music: "Starday" by Podington Bear. For information regarding your data privacy, visit acast.com/privacy
Music: "Starday" by Podington Bear. For information regarding your data privacy, visit acast.com/privacy
Released:
Sep 23, 2015
Format:
Podcast episode
Titles in the series (100)
Dubai World: Investor mood and long-term effects by FT News in Focus